Pfizer’s Oral COVID-19 Pill Paxlovid Tops Merck’s Molnupiravir

 
• By Joseph Haas
COVID-19 red cells on white
Pfizer's oral antiviral sharply reduces hospitalization/mortality risk in trial

More from COVID-19

More from Scrip